Donanemab Interactions
There are 45 drugs known to interact with donanemab. Of the total drug interactions, 42 are major, and 3 are moderate.
- View all 45 medications that may interact with donanemab
Most frequently checked interactions
View interaction reports for donanemab and the medicines listed below.
- Aspirin Low Strength (aspirin)
- Atripla (efavirenz / emtricitabine / tenofovir disoproxil)
- Botox (onabotulinumtoxinA)
- Calcium, Magnesium and Zinc (multivitamin with minerals)
- Centrum Silver (multivitamin with minerals)
- Claritin Reditabs (loratadine)
- CoQ10 (ubiquinone)
- Dayvigo (lemborexant)
- Depakene (valproic acid)
- Dexilant (dexlansoprazole)
- Emgality (galcanezumab)
- Flax Seed Oil (flax)
- Flexeril (cyclobenzaprine)
- Florastor (saccharomyces boulardii lyo)
- Imitrex (sumatriptan)
- Iron Sulfate (ferrous sulfate)
- K2 Plus D3 (multivitamin)
- Lyrica (pregabalin)
- Marcaine (bupivacaine)
- Metamucil (psyllium)
- Metoprolol Succinate ER (metoprolol)
- Mucus Relief (guaifenesin)
- Omega-3 Fish Oil (omega-3 polyunsaturated fatty acids)
- Ozempic (semaglutide)
- Pataday (olopatadine ophthalmic)
- Plavix (clopidogrel)
- PreserVision AREDS 2 (multivitamin with minerals)
- Prilosec OTC (omeprazole)
- Vitamin B12 (cyanocobalamin)
- Vitamin D3 (cholecalciferol)
More about donanemab
- donanemab consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: miscellaneous central nervous system agents
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.